Deutsch English Français

Contact

EP0502049

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0502049

EP0502049 - TUMOUR NECROSIS FACTOR ANTAGONIST [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 19.12.1996 Database last updated on 18.01.2025
Most recent event Tooltip	07.12.2007	Lapse of the patent in a contracting state Updated state(s): FR	published on 09.01.2008 [2008/02]
Applicant(s)	For all designated states XENOVA LIMITED 240 Bath Road Slough Berkshire SL1 4EF / GB
	[N/P]
Former [1992/37]	For all designated states XENOVA LIMITED 240 Bath Road Slough, Berkshire SL1 4EF / GB
Inventor(s)	01 / NORRIS, David, Bradley 240 Bath Road Slough Berkshire SL1 4EF / GB
	02 / DEPLEDGE, Paul 240 Bath Road Slough Berkshire SL1 4EF / GB
	03 / JACKSON, Andrew, Paul 81 Queensgate Drive Birstall Leicester / GB
	[1992/37]
Representative(s)	Woods, Geoffrey Corlett J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [1994/40]	Woods, Geoffrey Corlett J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Former [1992/37]	Woods, Geoffrey Corlett J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Application number, filing date	90917347.8	22.11.1990
	[1992/37]
	WO1990GB01801
Priority number, date	GB19890026611	24.11.1989 Original published format: GB 8926611
	[1992/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9107953
	Date:	13.06.1991
	Language:	EN
	[1991/13]
	Type:	A1 Application with search report
	No.:	EP0502049
	Date:	09.09.1992
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 13.06.1991 takes the place of the publication of the European patent application.
	[1992/37]
	Type:	B1 Patent specification
	No.:	EP0502049
	Date:	07.02.1996
	[1996/06]
Search report(s)	International search report - published on:	EP	13.06.1991
Classification	IPC:	A61K31/045	[1992/37]
	CPC:	A61K31/045 (EP,US); A61P29/00 (EP); A61P31/04 (EP); A61P31/12 (EP); A61P31/18 (EP); A61P35/00 (EP); (+) A61P43/00 (EP); A61P9/00 (EP) (-)
Designated contracting states	AT, BE, CH, DE, DK, FR, GB, IT, LI, LU, NL, SE [1992/37]
Title	German:	TUMOR-NEKROSE-FAKTOR-ANTAGONIST	[1992/37]
	English:	TUMOUR NECROSIS FACTOR ANTAGONIST	[1992/37]
	French:	ANTAGONISTE DE FACTEUR DE NECROSE TUMORALE	[1992/37]
Entry into regional phase	23.06.1992	National basic fee paid
	23.06.1992	Designation fee(s) paid
	23.06.1992	Examination fee paid
Examination procedure	14.06.1991	Request for preliminary examination filed International Preliminary Examining Authority: DE
	23.06.1992	Examination requested [1992/37]
	15.07.1994	Despatch of a communication from the examining division (Time limit: M06)
	25.01.1995	Reply to a communication from the examining division
	30.03.1995	Despatch of communication of intention to grant (Approval: Yes)
	22.06.1995	Communication of intention to grant the patent
	28.08.1995	Fee for grant paid
	28.08.1995	Fee for publishing/printing paid
Opposition(s)	08.11.1996	No opposition filed within time limit [1997/06]
Fees paid	Renewal fee
	09.10.1992	Renewal fee patent year 03
	08.11.1993	Renewal fee patent year 04
	15.11.1994	Renewal fee patent year 05
	09.11.1995	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	07.02.1996
	BE	07.02.1996
	CH	07.02.1996
	DK	07.02.1996
	FR	07.02.1996
	IT	07.02.1996
	LI	07.02.1996
	NL	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	[2006/14]
Former [2003/07]	AT	07.02.1996
	BE	07.02.1996
	CH	07.02.1996
	DK	07.02.1996
	IT	07.02.1996
	LI	07.02.1996
	NL	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	FR	05.07.1996
Former [1999/42]	AT	07.02.1996
	BE	07.02.1996
	CH	07.02.1996
	DK	07.02.1996
	IT	07.02.1996
	LI	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	FR	05.07.1996
Former [1998/15]	AT	07.02.1996
	BE	07.02.1996
	CH	07.02.1996
	DK	07.02.1996
	LI	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	FR	05.07.1996
Former [1997/28]	AT	07.02.1996
	BE	07.02.1996
	CH	07.02.1996
	LI	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	FR	05.07.1996
Former [1997/06]	AT	07.02.1996
	BE	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
	FR	05.07.1996
Former [1996/52]	AT	07.02.1996
	BE	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
Former [1996/44]	AT	07.02.1996
	SE	07.05.1996
	DE	08.05.1996
Former [1996/42]	AT	07.02.1996
	SE	07.05.1996
Former [N/P]	deleted
Cited in	International search	EP0341558 [ ] (BOEHRINGER INGELHEIM KG [DE], et al)
		[Y] - The Journal of Antibiotics, volume XLI, no. 1, 1988, Takeshi Ando et al.: "Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria Nigra", pages 25-30
		[X] - Nature, volume 330, 17 december 1987, K.J. Tracey et al. "Ant-cachectin/TNF monooclonal antibodies prevent septic shock during lethal bacteraemia", pages 662-664

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p